IRIS
PARISI, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 435
AS - Asia 403
NA - Nord America 337
SA - Sud America 59
AF - Africa 17
OC - Oceania 2
Totale 1.253
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 332
HK - Hong Kong 194
RU - Federazione Russa 170
IT - Italia 108
SG - Singapore 94
CN - Cina 92
BR - Brasile 54
IE - Irlanda 33
FR - Francia 32
DE - Germania 31
NL - Olanda 15
CI - Costa d'Avorio 14
AT - Austria 11
FI - Finlandia 10
SE - Svezia 8
GB - Regno Unito 7
IN - India 7
KR - Corea 5
BG - Bulgaria 3
AU - Australia 2
BD - Bangladesh 2
MX - Messico 2
PK - Pakistan 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BO - Bolivia 1
BY - Bielorussia 1
CA - Canada 1
CH - Svizzera 1
CY - Cipro 1
EC - Ecuador 1
EG - Egitto 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
KZ - Kazakistan 1
MA - Marocco 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 1.253
Salva come PNG Salva come JPEG
Città #
Hong Kong 192
Boardman 89
Singapore 57
Ashburn 43
Moscow 38
Dublin 31
Shenzhen 22
Chandler 17
The Dalles 17
Ancona 15
Fairfield 15
Nuremberg 15
Abidjan 14
Zhengzhou 12
Camerino 11
Des Moines 10
Rome 10
Seattle 10
Helsinki 9
Jacksonville 8
Shanghai 8
Vienna 8
Los Angeles 7
Washington 7
Ann Arbor 6
Guangzhou 6
Dallas 5
Florence 5
Lawrence 5
London 5
Princeton 5
Saint Louis 5
Seoul 5
Amsterdam 4
Houston 4
Matelica 4
Easley 3
Milan 3
Modena 3
Naples 3
Ningbo 3
San Diego 3
Santa Clara 3
Somma Vesuviana 3
Woodbridge 3
Bellante 2
Belo Horizonte 2
Brasília 2
Dresden 2
Giulianova 2
Lahore 2
Macerata 2
Mexico City 2
Monza 2
Mumbai 2
New York 2
San Mateo 2
Sant'Egidio alla Vibrata 2
Shaoxing 2
Stuttgart 2
Suzhou 2
Tolentino 2
Treviso 2
Turin 2
Visakhapatnam 2
Wuhan 2
Xi'an 2
Yiwu 2
Abelardo Luz 1
Acton 1
Amandola 1
Ankang 1
Aparecida de Goiânia 1
Arcos 1
Beijing 1
Belford Roxo 1
Bento Gonçalves 1
Boa Vista 1
Bologna 1
Cairo 1
Camboriú 1
Cambridge 1
Campinas 1
Capão do Leão 1
Casoria 1
Caçapava 1
Changsha 1
Chengdu 1
Chicago 1
Chiswick 1
Chongqing 1
Comilla 1
Conselheiro Lafaiete 1
Curitiba 1
Dhaka 1
Diadema 1
Dortmund 1
Elk Grove Village 1
Erbil 1
Estância Velha 1
Totale 829
Salva come PNG Salva come JPEG
Nome #
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 80
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 67
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study 45
Adjuvant treatment with Capecitabine in patients who received orthotopic liver transplantation with incidental diagnosis of intrahepatic cholangiocarcinoma. Implications on DPYD polymorphisms assessment: report of two cases and review of the literature 40
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 40
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry 38
Evaluation of prognostic factors for survival in transverse colon cancer 37
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 36
The PERSONS score: A new tool for cancer patients' symptom assessment in simultaneous care and home care settings 36
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer 35
Concurrent RAS and RAS/BRAF V600E Variants in Colorectal Cancer: More Frequent Than Expected? A Case Report 33
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies 33
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer 33
Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study 32
Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis 30
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 28
Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry 28
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma 27
What is known about theragnostic strategies in colorectal cancer 25
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM) 25
Post-induction Strategies in Metastatic Colorectal Cancer Patients Treated With First-Line Anti-EGFR-Based Treatment: A Systematic Review and Meta-Analysis 25
Multimodality treatment in metastatic gastric cancer: From past to next future 24
The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer 24
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status 23
How to best exploit immunotherapeutics in advanced gastric cancer: Between biomarkers and novel cell-based approaches 22
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers 21
Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With Nivolumab 21
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study 20
Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series 19
Topical menthol for treatment of chemotherapy-induced peripheral neuropathy 18
Communication in oncology between healthcare providers, patients, the scientific community, and the media: recommendations from the Italian Association of Medical Oncology (AIOM) 18
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population 18
The emerging role of immunotherapy in the treatment of anal cancer 18
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction 17
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer 16
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference 15
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience 15
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 15
Looking for a place for dose-dense TMZ regimens in GBM patients: An experience with MGMT exploratory evaluation 15
Timed-flat infusion of 5-fluorouracil with docetaxel and oxaliplatin as first-line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen 15
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population 14
Pemigatinib in pazienti affetti da colangiocarcinoma localmente avanzato o metastatico con fusione o riarrangiamento di FGFR2 pretrattati: analisi congiunta degli studi di coorte multicentrici, osservazionali, "real-world" francese PEMI-BIL e italiano PEMI-REAL 14
Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: Preliminary report of the FAMI-L1 study 14
Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study 14
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice 14
The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study 13
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemic 13
The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients 13
Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A “snapshot” from clinical practice 12
SEX-RELATED DIFFERENCES IN EFFICACY AND SAFETY OF IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA: SYSTEMATIC REVIEW AND META-ANALYSIS OF LANDMARK PHASE III TRIALS AND VALIDATION IN ROUTINE CLINICAL PRACTICE 12
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 12
Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: A retrospective multicenter study 12
Bone recurrence in early breast cancer patients: The paradox of aromatase inhibitors induced bone resorption 11
Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy 11
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report 10
Where are we with treatment options after first line in small cell lung cancer?-Report of two opposite cases treated with CAPTEM regimen and possible perspectives 10
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study 10
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours 10
Expression of pro-angiogenic factors as potential biomarkers in experimental models of colon cancer 9
Family History of Cancer as Potential Prognostic Factor in Stage III Colorectal Cancer: a Retrospective Monoinstitutional Study 9
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: An update from clinical practice 9
A case of segmental hepatic necrosis complicating oxaliplatin and capecitabine chemotherapy: A case report and review of the literature 8
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 8
Into the storms: Organising oncological home care services during natural disasters and global pandemics 8
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature 8
Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis 6
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome 5
Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis 5
Totale 1.421
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.179
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 0 0 1 4
2020/202137 2 4 4 1 9 0 0 5 2 4 2 4
2021/202231 0 2 0 0 0 2 1 1 13 1 6 5
2022/202371 5 3 4 10 0 11 0 2 18 7 10 1
2023/2024254 16 3 13 19 18 27 2 13 1 71 25 46
2024/20251.022 151 76 42 12 39 50 200 67 274 96 15 0
Totale 1.421